Interferon-γ and celecoxib inhibit lung-tumor growth through modulating M2/M1 macrophage ratio in the tumor microenvironment

References

• Ledford H Cancer treatment: the killer within Nature 2014 508 7494 24 26 24695297
   PubMed Web of Science ®Google Scholar
• Kantoff PW Higano CS Shore ND Sipuleucel-T immunotherapy for castration-resistant prostate cancer N Engl J Med 2010 363 5 411 422 20818862
   PubMed Web of Science ®Google Scholar
• Hodi FS O’Day SJ McDermott DF Improved survival with ipilimumab in patients with metastatic melanoma N Engl J Med 2010 363 8 711 723 20525992
   PubMed Web of Science ®Google Scholar
• Harvey RD Immunologic and clinical effects of targeting of PD-1 in lung cancer Clin Pharmacol Ther 2014 96 2 214 223 24690569
   PubMed Web of Science ®Google Scholar
• Topalian SL Hodi FS Brahmer JR Safety, activity, and immune correlates of anti-PD-1 antibody in cancer N Engl J Med 2012 366 26 2443 2454 22658127
   PubMed Web of Science ®Google Scholar
• Brahmer JR Tykodi SS Chow LQ Safety and activity of anti-PD-L1 antibody in patients with advanced cancer N Engl J Med 2012 366 26 2455 2465 22658128
   PubMed Web of Science ®Google Scholar
• Lipson EJ Sharfman WH Drake CG Durable cancer regression off-treatment and effective reinduction therapy with an anti-PD-1 antibody Clin Cancer Res 2013 19 2 462 468 23169436
   PubMed Web of Science ®Google Scholar
• Witz IP Levy-Nissenbaum O The tumor microenvironment in the post-PAGET era Cancer Lett 2006 242 1 1 10 16413116
   PubMed Web of Science ®Google Scholar
• Lewis CE Pollard JW Distinct role of macrophages in different tumor microenvironments Cancer Res 2006 66 2 605 612 16423985
   PubMed Web of Science ®Google Scholar
• Mantovani A Sica A Locati M New vistas on macrophage differentiation and activation Eur J Immunol 2007 37 1 14 16 17183610
   PubMed Web of Science ®Google Scholar
• Mantovani A Sica A Locati M Macrophage polarization comes of age Immunity 2005 23 4 344 346 16226499
   PubMed Web of Science ®Google Scholar
• Baj-Krzyworzeka M Szatanek R Weglarczyk K Baran J Zembala M Tumour-derived microvesicles modulate biological activity of human monocytes Immunol Lett 2007 113 2 76 82 17825925
   PubMed Web of Science ®Google Scholar
• Mantovani A Sozzani S Locati M Allavena P Sica A Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes Trends Immunol 2002 23 11 549 555 12401408
   PubMed Web of Science ®Google Scholar
• Martinez FO Sica A Mantovani A Locati M Macrophage activation and polarization Front Biosci 2008 13 453 461 17981560
   PubMed Web of Science ®Google Scholar
• Gordon S Alternative activation of macrophages Nat Rev Immunol 2003 3 1 23 35 12511873
   PubMed Web of Science ®Google Scholar
• Mantovani A Bottazzi B Colotta F Sozzani S Ruco L The origin and function of tumor-associated macrophages Immunol Today 1992 13 7 265 270 1388654
   PubMedGoogle Scholar
• Galdiero MR Garlanda C Jaillon S Marone G Mantovani A Tumor associated macrophages and neutrophils in tumor progression J Cell Physiol 2013 228 7 1404 1412 23065796
   PubMed Web of Science ®Google Scholar
• Ma J Liu L Che G Yu N Dai F You Z The M1 form of tumor-associated macrophages in non-small cell lung cancer is positively associated with survival time BMC Cancer 2010 10 112 20338029
   PubMed Web of Science ®Google Scholar
• Liu L Ge D Ma L Interleukin-17 and prostaglandin E2 are involved in formation of an M2 macrophage-dominant microenvironment in lung cancer J Thorac Oncol 2012 7 7 1091 1100 22534817
   PubMed Web of Science ®Google Scholar
• Davis MJ Tsang TM Qiu Y Macrophage M1/M2 polarization dynamically adapts to changes in cytokine microenvironments in Cryptococcus neoformans infection MBio 2013 4 3 e00264 13 23781069
   PubMed Web of Science ®Google Scholar
• Sica A Mantovani A Macrophage plasticity and polarization: in vivo veritas J Clin Invest 2012 122 3 787 795 22378047
   PubMed Web of Science ®Google Scholar
• Zhang H Li Z Wang K Combining sorafenib with celecoxib synergistically inhibits tumor growth of non-small cell lung cancer cells in vitro and in vivo Oncol Rep 2014 31 4 1954 1960 24549815
   PubMed Web of Science ®Google Scholar
• Zhang W Zhu XD Sun HC Depletion of tumor-associated macrophages enhances the effect of sorafenib in metastatic liver cancer models by antimetastatic and antiangiogenic effects Clin Cancer Res 2010 16 13 3420 3430 20570927
   PubMed Web of Science ®Google Scholar
• Bertram JS Janik P Establishment of a cloned line of Lewis lung carcinoma cells adapted to cell culture Cancer Lett 1980 11 1 63 73 7226139
   PubMed Web of Science ®Google Scholar
• Zhang Q Liu S Ge D Interleukin-17 promotes formation and growth of prostate adenocarcinoma in mouse models Cancer Res 2012 72 10 2589 2599 22461511
   PubMed Web of Science ®Google Scholar
• Dai F Liu L Che G The number and microlocalization of tumor-associated immune cells are associated with patient’s survival time in non-small cell lung cancer BMC Cancer 2010 10 220 20487543
   PubMed Web of Science ®Google Scholar
• Rahman MA Dhar DK Yamaguchi E Coexpression of inducible nitric oxide synthase and COX-2 in hepatocellular carcinoma and surrounding liver: possible involvement of COX-2 in the angiogenesis of hepatitis C virus-positive cases Clin Cancer Res 2001 7 5 1325 1332 11350902
   PubMed Web of Science ®Google Scholar
• Weidner N Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors Breast Cancer Res Treat 1995 36 2 169 180 8534865
   PubMed Web of Science ®Google Scholar
• Redente EF Dwyer-Nield LD Merrick DT Tumor progression stage and anatomical site regulate tumor-associated macrophage and bone marrow-derived monocyte polarization Am J Pathol 2010 176 6 2972 2985 20431028
   PubMed Web of Science ®Google Scholar
• Zhang M He Y Sun X A high M1/M2 ratio of tumor-associated macrophages is associated with extended survival in ovarian cancer patients J Ovarian Res 2014 7 1 19 24507759
   PubMed Web of Science ®Google Scholar
• Lanciotti M Masieri L Raspollini MR The role of M1 and M2 macrophages in prostate cancer in relation to extracapsular tumor extension and biochemical recurrence after radical prostatectomy Biomed Res Int 2014 2014 486798 24738060
   PubMed Web of Science ®Google Scholar
• DeNardo DG Brennan DJ Rexhepaj E Leukocyte complexity predicts breast cancer survival and functionally regulates responses to chemotherapy Cancer Discov 2011 1 1 54 67 22039576
   PubMed Web of Science ®Google Scholar
• Santoni M Massari F Amantini C Emerging role of tumor-associated macrophages as therapeutic targets in patients with metastatic renal cell carcinoma Cancer Immunol Immunother 2013 62 12 1757 1768 24132754
   PubMed Web of Science ®Google Scholar
• Pahl JH Kwappenberg KM Varypataki EM Macrophages inhibit human osteosarcoma cell growth after activation with the bacterial cell wall derivative liposomal muramyl tripeptide in combination with interferon-γ J Exp Clin Cancer Res 2014 33 27 24612598
   PubMed Web of Science ®Google Scholar
• Pander J Heusinkveld M van der Straaten T Activation of tumor-promoting type 2 macrophages by EGFR-targeting antibody cetuximab Clin Cancer Res 2011 17 17 5668 5673 21788356
   PubMed Web of Science ®Google Scholar
• Ibrahim A Scher N Williams G Approval summary for zoledronic acid for treatment of multiple myeloma and cancer bone metastases Clin Cancer Res 2003 9 7 2394 2399 12855610
   PubMed Web of Science ®Google Scholar
• Senzaki M Ishida S Yada A CS-706, a novel cyclooxygenase-2 selective inhibitor, prolonged the survival of tumor-bearing mice when treated alone or in combination with anti-tumor chemotherapeutic agents Int J Cancer 2008 122 6 1384 1390 18027868
   PubMed Web of Science ®Google Scholar
• Curnis F Gasparri A Sacchi A Cattaneo A Magni F Corti A Targeted delivery of IFNγ to tumor vessels uncouples antitumor from counter-regulatory mechanisms Cancer Res 2005 65 7 2906 2913 15805293
   PubMed Web of Science ®Google Scholar
• Hung TT Chan J Russell PJ Power CA Zoledronic acid preserves bone structure and increases survival but does not limit tumour incidence in a prostate cancer bone metastasis model PLoS One 2011 6 5 e19389 21603655
   PubMed Web of Science ®Google Scholar